Enlivex Therapeutics Ltd (ENLV)
1.46
-0.02
(-1.28%)
USD |
NASDAQ |
Jun 14, 16:00
1.45
-0.01
(-0.68%)
After-Hours: 20:00
Enlivex Therapeutics Enterprise Value: 0.1452M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 0.1452M |
| June 13, 2024 | 0.5027M |
| June 12, 2024 | -1.172M |
| June 11, 2024 | -0.6072M |
| June 10, 2024 | -1.736M |
| June 07, 2024 | -2.112M |
| June 06, 2024 | -1.360M |
| June 05, 2024 | -3.053M |
| June 04, 2024 | -1.924M |
| June 03, 2024 | 0.3333M |
| May 31, 2024 | -1.736M |
| May 30, 2024 | -1.926M |
| May 29, 2024 | -2.676M |
| May 28, 2024 | -1.360M |
| May 24, 2024 | -0.9835M |
| May 23, 2024 | -1.554M |
| May 22, 2024 | -0.231M |
| May 21, 2024 | 0.7096M |
| May 20, 2024 | -0.6072M |
| May 17, 2024 | -0.7954M |
| May 16, 2024 | -0.9835M |
| May 15, 2024 | -0.6072M |
| May 14, 2024 | -0.0429M |
| May 13, 2024 | 0.1452M |
| May 10, 2024 | 0.8977M |
| Date | Value |
|---|---|
| May 09, 2024 | 1.274M |
| May 08, 2024 | 1.838M |
| May 07, 2024 | 2.403M |
| May 06, 2024 | 2.214M |
| May 03, 2024 | 3.155M |
| May 02, 2024 | 3.155M |
| May 01, 2024 | 2.967M |
| April 30, 2024 | 4.096M |
| April 29, 2024 | 3.908M |
| April 26, 2024 | -0.231M |
| April 25, 2024 | -0.0429M |
| April 24, 2024 | 0.8977M |
| April 23, 2024 | -2.488M |
| April 22, 2024 | -3.429M |
| April 19, 2024 | -2.488M |
| April 18, 2024 | -0.9835M |
| April 17, 2024 | 0.5215M |
| April 16, 2024 | -0.0429M |
| April 15, 2024 | -2.865M |
| April 12, 2024 | 2.403M |
| April 11, 2024 | 7.106M |
| April 10, 2024 | 47.55M |
| April 09, 2024 | 49.43M |
| April 08, 2024 | 49.81M |
| April 05, 2024 | 47.93M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-7.999M
Minimum
May 05 2022
384.09M
Maximum
Sep 23 2019
62.63M
Average
39.70M
Median
Sep 30 2022
Enterprise Value Benchmarks
| Compugen Ltd | 84.02M |
| Pluri Inc | 29.63M |
| BioLine Rx Ltd | 34.84M |
| Can Fite Biofarma Ltd | 7.796M |
| BiomX Inc | -19.27M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.095M |
| Total Expenses (Quarterly) | 6.091M |
| EPS Diluted (Quarterly) | -0.48 |
| Earnings Yield | -106.8% |